Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations
Fatimah Al-Ani,1 Ian Chin-Yee,1 Alejandro Lazo-Langner1,2 1Department of Medicine, Division of Hematology, 2Department of Epidemiology and Biostatistics, Western University, London, ON, Canada Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) is a nonmalignant clonal disorder resulting from soma...
Main Authors: | Al-Ani F, Chin-Yee I, Lazo-Langner A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-08-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/eculizumab-in-the-management-of-paroxysmal-nocturnal-hemoglobinuria-pa-peer-reviewed-article-TCRM |
Similar Items
-
Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
by: Michael J. Fassett, et al.
Published: (2021-04-01) -
Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description
by: Endri Mauro, Filippo Gherlinzoni
Published: (2019-11-01) -
Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation
by: Brodsky Andrés, et al.
Published: (2012-09-01) -
Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01) -
Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01)